Biological age reversal, epigenetic clocks, senolytics, and anti-aging interventions
755 articles
UCSF study tests whether stress-reduction classes can reverse biological markers of cellular aging in overwhelmed caregivers.
Researchers used retinal imaging to detect brain amyloid and tested whether telomerase activation could reduce Alzheimer's markers.
French study reveals how diabetes triggers premature cellular aging that may lead to dangerous heart muscle weakening.
Comprehensive analysis of 100 centenarians identifies key biological markers associated with reaching 100+ years of age.
Natural Monarda didyma supplement tested in 81-person study for anti-aging effects. Results could reshape longevity strategies.
Polish study examines whether weight loss surgery can turn back the molecular clock by measuring telomere length changes over 24 months.
French researchers tracked how kidney failure and dialysis speed up immune cell aging, revealing new connections between organ health and longevity.
Small trial tests whether dasatinib plus quercetin can improve brain blood flow and cognition in at-risk older adults.
Clinical trial tests whether senolytic compounds can reduce cellular aging burden and improve bone health markers in older adults.
Clinical trial tests whether dasatinib plus quercetin can reduce liver scarring in fatty liver disease patients.
Six-month trial examines whether metformin treatment can improve telomere length and longevity gene expression in prediabetic individuals.
144-person study explores how rapamycin, amino acids, and resistance exercise combat sarcopenia and muscle wasting in aging adults.
